• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

India, China may start producing Sputnik V vaccine: Putin

expresspharmaNovember 18, 2020

Tag: COVID-19 , Sputnik V vaccine , china , India

India and China may start producing Russia’s Sputnik V vaccine against COVID-19, the RIA news agency cited President Vladimir Putin as saying.

Putin also proposed that the creation of a vaccine research centre for BRICS countries – Brazil, Russia, India, China and South Africa – be sped up, TASS reported.

Recently, RDIF and Gamaleya Institute had issued a statement claiming that as per interim trial results,  the Sputnik-V vaccine is 92 per cent effective at preventing COVID-19.

Previous:Foxx Life Sciences to open Asia headquarters in Medchal, Hyderabad

Next:T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

India, China may start producing Sputnik V vaccine: Putin | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

China factory supply Food Additive Potassium benzoate cas 582-25-2 with free Samples in stock

China factory supply Food Additive Potassium benzoate cas 582-25-2 with free Samples in stock
Spiramycin EP8.0 with GMP supplier Pharmaceutical API Antibiotic made in china

Spiramycin EP8.0 with GMP supplier Pharmaceutical API Antibiotic made in china
Calcium mupirocin dihydrate USP Pharmaceutical Antibacterial made in china

Calcium mupirocin dihydrate USP Pharmaceutical Antibacterial made in china
45ml china pharma capsule tablet packaging container

45ml china pharma capsule tablet packaging container
Flubendazole CPV/EP 99%min supplier Pharmaceutical API Anti parasitic drugs Veterinary made in china

Flubendazole CPV/EP 99%min supplier Pharmaceutical API Anti parasitic drugs Veterinary made in china
Gonadorelin supplier Pharmaceutical API Polypeptide made in china

Gonadorelin supplier Pharmaceutical API Polypeptide made in china
Top Virgin Olive Oil from China

Top Virgin Olive Oil from China
Ticarcillin disodium salt USP supplier Pharmaceutical API Antibiotic made in china

Ticarcillin disodium salt USP supplier Pharmaceutical API Antibiotic made in china
China Coatings

China Coatings
D-Galactose 98% supplier Carbohydrate Food Additive made in china

D-Galactose 98% supplier Carbohydrate Food Additive made in china

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service